30Oct/13

Organ Donation Bill passes third reading – CTV News


Globalnews.ca

Organ Donation Bill passes third reading
CTV News
Bill 207, the Human Tissue and Organ Donation Amendment Act passed its third reading in the Alberta Legislature Tuesday, and the government hopes it will go on to help improve organ donation rates in the province. The legislation was brought forward, 
Alberta passes organ donation billGlobalnews.ca
Fewer brain deaths hurting organ donation rates, study findsCalgary Herald
Fewer patients with brain injury progressing to ‘brain death’Fox News
National Post –Nottingham Post –Edmonton Journal
all 30 news articles »
30Oct/13

“Molecular Velcro” may lead to cost-effective alternatives to natural antibodies – R & D Magazine

“Molecular Velcro” may lead to cost-effective alternatives to natural antibodies
R & D Magazine
Taking inspiration from the human immune system, researchers at the U.S. Dept. of Energy (DOE)’s Lawrence Berkeley National Laboratory (Berkeley Lab) have created a new material that can be programmed to identify an endless variety of molecules.

and more »

30Oct/13

'Molecular Velcro' may lead to cost-effective alternatives to natural antibodies – Science Daily (press release)

‘Molecular Velcro’ may lead to cost-effective alternatives to natural antibodies
Science Daily (press release)
Oct. 30, 2013 — Taking inspiration from the human immune system, researchers at the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) have created a new material that can be programmed to identify an endless variety of 

and more »

30Oct/13

More than a Third of Chronic Kidney Disease-Non-Dialysis Patients are Likely … – PR Newswire (press release)

More than a Third of Chronic Kidney Disease-Non-Dialysis Patients are Likely
PR Newswire (press release)
EXTON, Pa., Oct. 30, 2013 /PRNewswire/ — BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that, while familiarity with FibroGen/Astellas/AstraZeneca’s FG-4592/ASP1517 is 

and more »